secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001387131-23-009019
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix prices $7M public offering of common stock and warrants to fund operations
--------------------------------------------------------------------------------

- Priced $7M public offering: 2.53M shares + pre-funded warrants for 4.47M shares + 7M common warrants at $1.00 per unit.
- Gross proceeds ~$7M; net proceeds for working capital, facility build-out, and product acquisition/licensing.
- Common warrants exercisable at $1.00/share, expire 5 years from issuance.
- Lock-up: directors/officers restricted from selling for 60 days post-closing.
- Closing expected August 1, 2023; A.G.P. and Brookline Capital Markets acting as placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/0001387131-23-009019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713123009019/tnxp_8k-072423.htm
  HTML page:      https://secwatch.observer/filing/0001387131-23-009019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer